US Stock Insider Trading | Rapid Micro disclosed 3 insider transactions on February 20

2026-02-21 20:15:20

On February 20, 2026, Rapid Micro (RPID) disclosed three insider trading transactions. Director Robert G. Spignesi Jr. sold 38,300 shares.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 20, 2026	Executive	WIRTJES SEAN M	February 20, 2026	Sell	17,300	3.92	67,700
February 20, 2026	Director	Robert G. Spignesi Jr.	February 19, 2026	Sell	38,300	3.89	148,900
February 20, 2026	Executive	Wilson John J. Addington	February 20, 2026	Sell	5,403	3.92	21,200
February 10, 2026	Director	Robert G. Spignesi Jr.	February 9, 2026	Sell	12,800	3.78	48,600
February 10, 2026	Executive	Wilson John J. Addington	February 9, 2026	Sell	4,610	3.78	17,400
February 10, 2026	Executive	WIRTJES SEAN M	February 9, 2026	Sell	6,027	3.78	22,800
February 6, 2026	Shareholder holding over 10%	Longitude Capital Partners II, LLC	February 4, 2026	Sell	49,000	3.88	190,100
February 3, 2026	Shareholder holding over 10%	Longitude Capital Partners II, LLC	January 23, 2026	Buy	629,000	0.05	31,500
February 3, 2026	Shareholder holding over 10%	Longitude Capital Partners II, LLC	February 2, 2026	Sell	27,500	4.25	116,800
February 3, 2026	Shareholder holding over 10%	Longitude Capital Partners II, LLC	February 3, 2026	Sell	27,500	4.24	116,600

[Company Information]

Rapid Micro Biosystems, Inc. was incorporated on December 29, 2006, under Delaware law. The company is an innovative life sciences technology firm providing automation solutions to facilitate efficient manufacturing and rapid, safe release of healthcare products such as bioprocessing, vaccines, cell and gene therapies, and sterile injectables. The company develops, manufactures, and sells proprietary consumables for the Growth Direct system, laboratory information management system (“LIMS”) connection software, and services to address rapid microbial testing for quality control in the manufacturing of pharmaceuticals, medical devices, and personal care products. The company currently sells products to customers in North America, Europe, and Asia.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes